Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced chiral resolution technology for Crizotinib intermediates ensures high purity and cost reduction in API manufacturing for global supply chains.
Novel patent CN112939900B offers high-yield brivaracetam intermediate synthesis with simplified chiral resolution for reliable pharmaceutical intermediate supply chains.
Patent CN104557572A reveals a safer synthesis route for Levalbuterol hydrochloride. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel patent CN118580192B details efficient chiral intermediate synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing partners globally.
Patent CN103288801B reveals a novel method for high-purity esomeprazole sodium. Achieves superior chiral purity and eliminates titanium residue for reliable supply.
Patent CN117105887A reveals a novel Salen Co-catalyzed resolution for chiral epichlorohydrin. Achieve high purity, catalyst recycling, and significant cost reduction in pharmaceutical manufacturing.
Patent CN103288630A details a novel synthesis of Sodium Danshensu from L-Tyrosine. This report analyzes the DKR strategy for cost-effective, high-purity API intermediate manufacturing.
Novel resolution method for chiral chloroquine phosphate ensures high optical purity and scalable production for pharmaceutical supply chains globally.
Novel vinyl ester amidation route for dihydro-1,3,5-triazine derivatives. High purity, scalable chiral resolution for diabetes treatment intermediates.
Patent CN111205251B details a novel synthesis for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-carbamic acid benzyl ester, offering significant cost reduction and scalable manufacturing for chiral catalysts.
Novel enzymatic route for Sacubitril intermediates offers cost reduction in API manufacturing. High-purity cardiovascular drug synthesis suitable for commercial scale-up.
Novel resolution-before-condensation route for Ramosetron HCl. Reduces N-methylindole consumption and boosts yield for scalable API manufacturing.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Discover advanced manufacturing of chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylates. A robust resolution process for calcium antagonist intermediates ensuring high purity and supply stability.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.
Novel chiral resolution method for captopril intermediate ensures high purity and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Patent CN110938028B details a cost-effective, three-step synthesis of high-purity (1R)-5-bromo-2,3-dihydro-1-methyl-1H-isoindole, optimizing supply chain stability for quinolone antibiotics.
Patent CN115246815A details a novel nicotine preparation method recycling chiral resolution waste, offering high purity and reduced environmental impact for pharmaceutical manufacturers.
Novel patent CN117447387A enables cost-effective chiral intermediate production. Enhances supply chain reliability and purity for global API manufacturing partners.
Novel green synthesis of Dapoxetine from acetophenone. Improved yield, reduced waste, scalable industrial process for pharmaceutical intermediates.